NASDAQ: YDES
Yd Biopharma Ltd Stock Ownership - Who owns Yd Biopharma?

Insider buying vs selling

Have Yd Biopharma Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when YDES insiders and whales buy or sell their stock.

YDES Shareholders

What type of owners hold Yd Biopharma Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
J. Douglas Ramsey3.67%2,575,000$14.06MInsider
Geode Capital Management LLC0.08%58,363$318.66kInstitution
Cerity Partners LLC0.05%32,406$176.94kInstitution
Cypress Capital Management LLC Wy0.04%27,540$150.37kInstitution
Citadel Advisors LLC0.02%11,549$63.06kInstitution
Ubs Group Ag0.01%7,192$39.27kInstitution
Wolverine Asset Management LLC0.00%2,516$13.74kInstitution
Citigroup Inc0.00%1,709$9.33kInstitution
Morgan Stanley0.00%299$1.63kInstitution
Bank Of America Corp0.00%5$27.30Institution

1 of 2

YDES vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
YDES0.20%3.67%
XFOR91.80%8.20%Net Buying
PBYI61.74%38.26%Net Selling
AKBA44.14%8.15%Net SellingNet Selling
ENTA64.96%35.04%Net SellingNet Selling

Yd Biopharma Stock Ownership FAQ

Who owns Yd Biopharma?

Yd Biopharma (NASDAQ: YDES) is owned by 0.20% institutional shareholders, 3.67% Yd Biopharma insiders, and 96.12% retail investors. J. Douglas Ramsey is the largest individual Yd Biopharma shareholder, owning 2.58M shares representing 3.67% of the company. J. Douglas Ramsey's Yd Biopharma shares are currently valued at $14.06M.

If you're new to stock investing, here's how to buy Yd Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.